Share Market Newspaper

Discovery Point Retreat reports reductions in depression, anxiety and substance use severity across its Texas programs

Discovery Point Retreat reports reductions in depression, anxiety and substance use severity across its Texas programs

Discovery Point Retreat outcomes data, March to September 2026 Discovery Point Retreat released March to September 2026 outcomes data from its Ennis, Waxahachie and Dallas programs, covering 905 paired clients

Read Full Article

Advanced Renal Cell Carcinoma Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2034 – DelveInsight | Pfizer, AbbVie, Bristol-Myers Squibb, Abbott, Takeda, Amgen, Novartis

The Key Advanced Renal Cell Carcinoma Companies in the market include- Dana-Farber Cancer Institute, Huabo Biopharm Co., Ltd., Beijing Scitech-Mq Pharmaceuticals, Oxford BioMedica, Hutchison Medipharma Limited, Takeda, Amgen, Novartis, AVEO

Read Full Article

Cholangiocarcinoma Market Size, Emerging Therapies, and Forecast Insights Through 2034 – DelveInsight | Astrazeneca, Decalth Systems, Basilea Pharmaceuticals, Taiho Oncology, Eisai Pharmaceuticals

The Key Cholangiocarcinoma Companies in the market include – Incyte, Agios Pharmaceuticals, Servier Pharmaceuticals, Taiho Pharma, Astrazeneca, Decalth Systems, Basilea Pharmaceuticals, Taiho Oncology, Eisai Pharmaceuticals, TransThera Sciences (Nanjing), Inc., and

Read Full Article

Triple Negative Breast Cancer Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Akeso Biopharma, ProLynx, ModernaTX, OncoTherapy Science, Phoenix Molecular

The Key Triple Negative Breast Cancer Companies in the market include – Sichuan Kelun-Biotech Biopharmaceutical, Akeso Biopharma, ProLynx, ModernaTX, Inc., OncoTherapy Science, Phoenix Molecular Designs, Abbisko Therapeutics, BioLite, Inc., Zenith

Read Full Article

NSCLC Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Merck

(Albany, New York) – October 13, 2026: As per DelveInsight’s assessment, globally, Non-Small Cell Lung Cancer pipeline constitutes 100+ key

Read Full Article

Retinopathy of Prematurity Market is Projected to Grow by 2036 Owing to the Increasing Adoption of Anti-VEGF Therapies and Emerging Treatment Approaches

The market dynamics for Retinopathy of Prematurity (ROP) are expected to witness steady growth, driven by the increasing incidence of

Read Full Article

Osteogenesis Imperfecta Market Osteogenesis Imperfectased to Grow from USD 30 Million in 2023 to USD 500 Million by 2034 as First Targeted Therapies Near Approval

(Albany, New York) – October 13, 2026: DelveInsight’s “Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast – 2034” report offers an

Read Full Article

Ewing Sarcoma Epidemiology Forecast Through 2036 Now Available, Reports DelveInsight

Ewing sarcoma is a malignant small round cell tumor characterized by specific genetic fusions, primarily affecting bones and soft tissues

Read Full Article

Age-Related Macular Degeneration Market Valued at USD 9,840 Million in 2021, Set for Further Growth Through 2034Age-Related Macular Degeneration Market

AMD is characterized by progressive degeneration of the macula, the central part of the retina, and can be classified as

Read Full Article

Bronx LGBTQ Divorce Attorney Juan Luciano Addresses Common Questions About Same Gender Divorce in New York

BRONX, NY – October 12, 2026 – Divorces involving LGBTQ spouses proceed under the same New York statutes as any

Read Full Article